Cell Therapies for Atrophic AMD

Related

• 

  Quantitative Contrast Sensitivity Longitudinal Changes Correlate Better Than Visual Acuity With Geographic Atrophy Progression

  John B. Miller, MD

  Annual Meeting Talks

  2024

• 

  Safety and Efficacy of Switching to Biosimilar Ranibizumab in Eyes Initially Treated With Reference Ranibizumab for nAMD, DME, or RVO

  Nikhil K Bommakanti, MD

  Annual Meeting Talks

  2024

• 

  GATHER2 Phase 3 Efficacy Results and GATHER2 Phase 3 Safety Results

  Jeffrey S. Heier, MD

  Arshad M. Khanani, MD, MA, FASRS

  Updates from the Field

  2022